RhodesAEvansLEAlhazzaniW. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. In press.
2.
RussellJAWalleyKRSingerJ. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877-887.
3.
DunserMWMayrAJTurA. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med. 2003;31:1394-1398.
4.
HallLGOyenLJTanerCB. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacotherapy. 2004;24:1002-1012.
5.
SzumitaPMEnfantoCMGreenwoodBWechslerME.Vasopressin for vasopressor-dependent septic shock. Am J Health Syst Pharm. 2005;62:1931-1936.
6.
RussellJAWalleyKRGordonAC. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009;37:811-818.
7.
GordonACMasonAJThirunavukkarasuN. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509-518.
